| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 11 | 2023 | 468 | 1.710 |
Why?
|
| Breast Neoplasms | 13 | 2024 | 2507 | 1.440 |
Why?
|
| Nuclear Receptor Coactivator 3 | 7 | 2020 | 348 | 0.790 |
Why?
|
| Endocrine Disruptors | 3 | 2020 | 52 | 0.610 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2024 | 721 | 0.580 |
Why?
|
| Breast | 2 | 2018 | 215 | 0.570 |
Why?
|
| Transcription, Genetic | 8 | 2020 | 1702 | 0.550 |
Why?
|
| Proteomics | 3 | 2018 | 491 | 0.540 |
Why?
|
| E1A-Associated p300 Protein | 4 | 2020 | 52 | 0.540 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2021 | 1899 | 0.520 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 211 | 0.500 |
Why?
|
| MCF-7 Cells | 9 | 2020 | 222 | 0.490 |
Why?
|
| Estrogens | 6 | 2024 | 515 | 0.470 |
Why?
|
| Response Elements | 2 | 2015 | 97 | 0.450 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 483 | 0.430 |
Why?
|
| DNA | 3 | 2020 | 1599 | 0.430 |
Why?
|
| Nucleosomes | 1 | 2013 | 38 | 0.430 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 389 | 0.410 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 2055 | 0.410 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 397 | 0.390 |
Why?
|
| HeLa Cells | 8 | 2017 | 809 | 0.360 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 112 | 0.330 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 256 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 549 | 0.290 |
Why?
|
| Signal Transduction | 6 | 2020 | 4535 | 0.290 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 669 | 0.290 |
Why?
|
| Endometriosis | 2 | 2024 | 177 | 0.280 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 414 | 0.280 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3342 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 1341 | 0.260 |
Why?
|
| Trans-Activators | 2 | 2013 | 807 | 0.260 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1272 | 0.240 |
Why?
|
| Genes, ras | 1 | 2004 | 97 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2024 | 41 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 57 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 206 | 0.220 |
Why?
|
| Protein Binding | 5 | 2020 | 1749 | 0.220 |
Why?
|
| Transcription Factors | 4 | 2017 | 2608 | 0.210 |
Why?
|
| Estrogen Antagonists | 2 | 2020 | 103 | 0.210 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 275 | 0.200 |
Why?
|
| Glucose | 2 | 2018 | 885 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2020 | 363 | 0.200 |
Why?
|
| Humans | 30 | 2024 | 124409 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2024 | 887 | 0.190 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 62 | 0.180 |
Why?
|
| Apoptosis | 3 | 2024 | 1790 | 0.180 |
Why?
|
| Animals | 16 | 2024 | 34147 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2018 | 1625 | 0.170 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.170 |
Why?
|
| Stilbenes | 1 | 2020 | 36 | 0.170 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1459 | 0.170 |
Why?
|
| Models, Biological | 3 | 2020 | 1459 | 0.170 |
Why?
|
| Trialkyltin Compounds | 1 | 2019 | 7 | 0.170 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2019 | 19 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 187 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 42 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 212 | 0.170 |
Why?
|
| Histones | 3 | 2017 | 534 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 69 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 238 | 0.160 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 207 | 0.160 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 675 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2019 | 229 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 355 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 37 | 0.140 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2017 | 9 | 0.140 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 14 | 0.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 43 | 0.140 |
Why?
|
| Mutation | 5 | 2023 | 5805 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 100 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 51 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 701 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 357 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 120 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 197 | 0.130 |
Why?
|
| Female | 15 | 2024 | 66307 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 356 | 0.130 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.130 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 14 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2016 | 71 | 0.130 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 66 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 158 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2304 | 0.120 |
Why?
|
| Luciferases | 3 | 2013 | 135 | 0.120 |
Why?
|
| Chromatin | 1 | 2018 | 554 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1288 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2019 | 1174 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2020 | 753 | 0.120 |
Why?
|
| Mice | 9 | 2024 | 17729 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1674 | 0.110 |
Why?
|
| Binding Sites | 4 | 2018 | 1296 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2017 | 749 | 0.110 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 18 | 0.110 |
Why?
|
| Receptors, Estrogen | 3 | 2024 | 794 | 0.110 |
Why?
|
| Models, Molecular | 3 | 2020 | 1075 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 60 | 0.110 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2013 | 12 | 0.110 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1393 | 0.110 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 94 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2535 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2013 | 89 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 670 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2016 | 1108 | 0.100 |
Why?
|
| Cryoelectron Microscopy | 3 | 2020 | 214 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 121 | 0.100 |
Why?
|
| Homeostasis | 1 | 2015 | 692 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 137 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 59 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 366 | 0.090 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2010 | 7 | 0.090 |
Why?
|
| RNA Interference | 3 | 2018 | 503 | 0.090 |
Why?
|
| Liver | 1 | 2017 | 1761 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 104 | 0.080 |
Why?
|
| Transfection | 3 | 2017 | 1069 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2015 | 313 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2021 | 710 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 577 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 756 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 332 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1064 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 806 | 0.070 |
Why?
|
| Estradiol | 2 | 2020 | 534 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1024 | 0.070 |
Why?
|
| Endometrium | 2 | 2024 | 282 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 572 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1531 | 0.070 |
Why?
|
| Acetylation | 2 | 2017 | 175 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1598 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 664 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1015 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 840 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2020 | 677 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 833 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2251 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 571 | 0.060 |
Why?
|
| Silver Staining | 1 | 2004 | 5 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 70 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2004 | 64 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 43 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 44 | 0.060 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 63 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 90 | 0.060 |
Why?
|
| Transcriptome | 2 | 2021 | 937 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 767 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2004 | 383 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 211 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2771 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1695 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 229 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 203 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10150 | 0.050 |
Why?
|
| Piperazines | 1 | 2024 | 233 | 0.050 |
Why?
|
| Rats | 2 | 2020 | 3687 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 625 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2800 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 67 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 30 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 94 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 4553 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 645 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 77 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 144 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 530 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2699 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 82 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 35 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 184 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 2019 | 30 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 879 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 301 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 35 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4355 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 200 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 234 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 122 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 290 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 164 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 536 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 136 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4425 | 0.040 |
Why?
|
| Mammals | 1 | 2019 | 260 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 191 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 41 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 764 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 110 | 0.040 |
Why?
|
| TATA Box | 1 | 1997 | 25 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 147 | 0.040 |
Why?
|
| TATA-Box Binding Protein | 1 | 1997 | 30 | 0.040 |
Why?
|
| Methylation | 1 | 2017 | 224 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 162 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2020 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 295 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 393 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1688 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 60 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 528 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 340 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 223 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 1584 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2013 | 36 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 66 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1228 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1660 | 0.030 |
Why?
|
| Base Sequence | 1 | 1997 | 3094 | 0.030 |
Why?
|
| Drosophila | 1 | 2017 | 781 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1684 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3873 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 64 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 514 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 892 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 723 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 374 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2824 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 316 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 606 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1318 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 835 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3753 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6273 | 0.020 |
Why?
|
| Male | 2 | 2020 | 61033 | 0.010 |
Why?
|